SUMMARY A prospective, randomised, single-blind trial was carried out to compare the efficacy and tolerability of minocycline and ampicillin in the treatment of gonorrhoea in men. One hundred and twenty men were treated with minocycline 300 mg and 121 men with ampicillin 2 g and probenecid 1 g. Cure rates were similar in both groups of patients. There were few side effects.
Introduction
Ampicillin has gained a place in the treatment of gonorrhoea since the early reports of Willcox (1963) and Alergant (1963) . Used by itself there have been unacceptably high failure rates. Gundersen et al. (1969) , as have others since, showed that the addition of probenecid, which blocks the renal excretion of penicillin causing a higher serum concentration, alleviated this problem. Adler (1978a) found that ampicillin was the most commonly prescribed antimicrobial for men with gonorrhoea in England and Wales, being used together with probenecid in onethird of clinics. It has no effect, however, when used as pivampicillin (Pondocillin) (an ampicillin derivative) on the development of PGU (Waugh and Nayyar, 1977) . Minocycline hydrochloride, a semisynthetic derivative of tetracycline (7-dimethylamine-6-deoxy-6-demethyl tetracycline hydrochloride), has been found to be of use in the treatment of gonorrhoea since the findings-albeit with differing results-of Pariser and Marino (1970) and Duncan et al. (1971) . In the United Kingdom Shahidullah (1975) and Masterton and Schofield (1976) were found in the urethral smear, or in shreds from centrifuged urine specimens, PGU was considered to be present. Patients were then treated with triple tetracycline (chlortetracycline hydrochloride 115-4 mg, tetracycline hydrochloride 115-4 mg, demeclocycline hydrochloride 69-2 mg; Deteclo) one tablet twice daily for 14 days. The patient was clinically cured if his discharge and other symptoms of urethritis had disappeared and if Neisseria gonorrhoeae was not found on microscopy or culture.
On each return visit, the patient was asked if he had noticed any side effects of treatment and if he had had coitus recently.
Any patient who was allergic to penicillin or tetracycline, was a habitual defaulter, was suspected of having syphilis, or had been given antimicrobials in the previous two weeks was excluded.
AGE, NATIONALITY AND PREVIOUS STD
The mean age, standard deviation (years), nationalities, and previous history of STD of the two groups are shown in Table 1 . The symptoms and signs of dysuria and discharge for the two groups are given in Table 2 
POST-GONOCOCCAL URETHRITIS
In group A, PGU occurred in 31 of 100 patients followed up. In group B it occurred in 34 (34' 3%) of 99 patients followed up; the difference was not significant (x2 = 0 12; P>0' 5, Yates's modification).
SIDE EFFECTS
Group A One patient reported vomiting after medication but on follow up was found to be cured. Group B One patient developed a widespread purpuric eruption after 48 hours and was found to have glandular fever; one other developed candidal balanoposthitis within a week of treatment.
RESULTS OF SENSITIVITY TESTS
These are shown in Table 6 . Penicillin Strains which were considered to be fully sensitive had an MIC of <0' 1 jg/ml, those with a reduced Mg/ml, and those resistant an MIC of >1 '0,g/ml.
Ninety-two strains were fully sensitive, 36 had a reduced sensitivity, and seven were resistant.
Discussion
Both minocycline and ampicillin with probenecid were found to be effective forms of treatment, there being no significant difference in the outcome in either group. There were minimal side effects and, as a result of careful history taking, no allergic reactions, although the well-known clinical picture of ampicillin rash in glandular fever was seen.
The default rate of 42 (17'47o) in 241 patients illustrates the importance of therapy that will be rapidly successful. It is probable that those patients who did not return were cured.
PGU rates (31%o for minocycline and 34' 3% for ampicillin with probenecid) were higher than in a previous trial (Waugh and Nayyar, 1977) , in which 33 (23 '4%) of 141 men treated with pivampicillin 1400 mg with probenecid Ig had PGU. The diagnostic criterion was then more than 10 pus cells per high power field. Again the PGU rate of 31 % for minocycline was much higher than that of 11' 8% reported by Shahidullah (1975) and that of 5 1010 reported by Masterton and Schofield (1976) . The observation of Adler (1978b) 
